BE704290A - - Google Patents

Info

Publication number
BE704290A
BE704290A BE704290DA BE704290A BE 704290 A BE704290 A BE 704290A BE 704290D A BE704290D A BE 704290DA BE 704290 A BE704290 A BE 704290A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE704290A publication Critical patent/BE704290A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE704290D 1966-09-27 1967-09-26 BE704290A (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2213566A IT1053661B (it) 1966-09-27 1966-09-27 Ammidi dell acido 3 5 metil 5 3 pirazol carbossilico

Publications (1)

Publication Number Publication Date
BE704290A true BE704290A (it) 1968-02-01

Family

ID=11192002

Family Applications (1)

Application Number Title Priority Date Filing Date
BE704290D BE704290A (it) 1966-09-27 1967-09-26

Country Status (9)

Country Link
BE (1) BE704290A (it)
CH (1) CH479588A (it)
DE (1) DE1670466A1 (it)
ES (1) ES345849A1 (it)
FR (1) FR7254M (it)
GB (1) GB1209326A (it)
IT (1) IT1053661B (it)
NL (1) NL6713145A (it)
SE (1) SE333147B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495195A (en) * 1982-11-01 1985-01-22 Eli Lilly And Company Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2534221A1 (en) * 2003-08-07 2005-02-24 Merck & Co., Inc. Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
US7998996B2 (en) 2004-02-17 2011-08-16 Laboratorios Del Dr. Esteve S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
EP1637522A1 (en) * 2004-09-16 2006-03-22 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
TW200533657A (en) 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
CA2556568A1 (en) * 2004-02-17 2005-08-25 Laboratorios Del Dr. Esteve S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
US7897589B2 (en) 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743889A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
WO2007009706A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
EP1743890A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
EP1743892A1 (en) 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
ES2336883B1 (es) * 2005-07-15 2011-03-22 Laboratorios Del Dr. Esteve, S.A. Compuestos de pirazolina sustituidos, con una estereoquimica predeterminada, para la reduccion de trigliceridos en sangre.
EP1746090A1 (en) * 2005-07-15 2007-01-24 Laboratorios del Dr. Esteve S.A. Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
EP1950202A1 (en) * 2007-01-24 2008-07-30 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments with ACAT inhibition activity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495195A (en) * 1982-11-01 1985-01-22 Eli Lilly And Company Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use

Also Published As

Publication number Publication date
DE1670466A1 (de) 1972-01-27
SE333147B (sv) 1971-03-08
IT1053661B (it) 1981-10-10
GB1209326A (en) 1970-10-21
NL6713145A (it) 1968-03-28
CH479588A (it) 1969-10-15
ES345849A1 (es) 1968-11-16
FR7254M (it) 1969-09-08

Similar Documents

Publication Publication Date Title
FR7254M (it)
AU5917865A (it)
AU424443B2 (it)
AU428063B2 (it)
AU414526B2 (it)
AU421822B2 (it)
AU433222B2 (it)
AU6703465A (it)
AU5895065A (it)
AU612166A (it)
BE447356A (it)
BE694589A (it)
BE284991A (it)
AU92366A (it)
AU855865A (it)
AU6852465A (it)
BE475118A (it)
BE529218A (it)
BE597652A (it)
BE618801A (it)
BE674777A (it)
BE624001A (it)
AU433620A (it)
BE624223A (it)
BE626310A (it)